APA (7th ed.) Citation

Schmitt, T., Goldschmidt, H., Neben, K., Freiberger, A., Hüsing, J., Gronkowski, M., . . . Egerer, G. (2014). Aprepitant, Granisetron, and Dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose Melphalan in autologous transplantation for multiple myeloma: Results of a randomized, placebo-controlled phase III trial. Journal of clinical oncology, 32(30), . https://doi.org/10.1200/JCO.2013.55.0095

Chicago Style (17th ed.) Citation

Schmitt, Thomas, et al. "Aprepitant, Granisetron, and Dexamethasone for Prevention of Chemotherapy-induced Nausea and Vomiting After High-dose Melphalan in Autologous Transplantation for Multiple Myeloma: Results of a Randomized, Placebo-controlled Phase III Trial." Journal of Clinical Oncology 32, no. 30 (2014). https://doi.org/10.1200/JCO.2013.55.0095.

MLA (9th ed.) Citation

Schmitt, Thomas, et al. "Aprepitant, Granisetron, and Dexamethasone for Prevention of Chemotherapy-induced Nausea and Vomiting After High-dose Melphalan in Autologous Transplantation for Multiple Myeloma: Results of a Randomized, Placebo-controlled Phase III Trial." Journal of Clinical Oncology, vol. 32, no. 30, 2014, https://doi.org/10.1200/JCO.2013.55.0095.